Discovery of Benzopyridone-Based Transient Receptor Potential Vanilloid 1 Agonists and Antagonists and the Structural Elucidation of Their Activity ShiftJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-01-0113PRE
t-Butyl pyridine and phenyl C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonistsBIOORGANIC & MEDICINAL CHEMISTRYIF32017-04-019OAAI
Harnessing the Therapeutic Potential of Capsaicin and Its Analogues in Pain and Other DiseasesMOLECULESIF4.62016-07-23151OAAI
2-Sulfonamidopyridine C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonistsBIOORGANIC & MEDICINAL CHEMISTRYIF32016-03-0110OAAI
Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonistsBIOORGANIC & MEDICINAL CHEMISTRYIF32015-11-017OAAI
5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1 expressionBIOORGANIC & MEDICINAL CHEMISTRYIF32015-11-0116PREAI
Role of computer-aided drug design in modern drug discoveryARCHIVES OF PHARMACAL RESEARCHIF7.52015-07-25485PREAI
Transient receptor potential vanilloid type 1 antagonists: a patent review (2011-2014)EXPERT OPINION ON THERAPEUTIC PATENTSIF4.62015-02-1066PREAI